CSIMarket
 

Warby Parker Inc   (NYSE: WRBY)

Warby Parker Inc 's

Competitiveness




 

WRBY Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Warby Parker Inc reported Revenue increase in the 1 quarter 2026 by 8.55 % year on year.
The revenue growth was below Warby Parker Inc 's competitors' average revenue growth of 10.15 %, achieved in the same quarter.

List of WRBY Competitors

With a net margin of 1.31 % Warby Parker Inc reported lower profitability than its competitors.

More on WRBY Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Warby Parker Inc Net Income in the 1 quarter 2026 fell year on year by -8.5%, while most of its competitors have experienced a contraction in net income by -50.64 %.

<<  WRBY Stock Performance Comparisons


Warby Parker Inc 's Comment on Competition and Industry Peers


The eyewear industry is concentrated, with a few major companies controlling significant portions of the value chain. Competition among these companies is based on brand image, product quality, price, innovation, and style. Warby Parker competes directly with large integrated optical companies such as EssilorLuxottica and VSP, which own and license multiple frame and lens brands, retail stores, online platforms, vision insurance plans, and optical lab networks. Warby Parker also faces competition from low-priced, online-only retailers like Zenni Optical.



  

Overall company Market Share Q1 2026

Revenue in Overall company grew by 8.55 %, less than Warby Parker Inc peers within this division.
<<  More on WRBY Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Warby Parker Inc




The Cooper Companies Inc
Share Performance



-8.81%
30 Days



The Cooper Companies Inc
Profile

The Cooper Companies Inc is a global medical device firm focused on manufacturing and distributing contact lenses and womens healthcare products. Its business model emphasizes innovation, strong distribution, strategic acquisitions, and partnerships to enhance market presence, targeting the specific needs of customers in eye care and womens health. Through research and development, they aim to improve customer lives while maximizing shareholder value.

More about The Cooper Companies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13,199.550 mill. $ 4,230.400 mill. $ 235.800 mill.


Staar Surgical Co
Share Performance



-0.21%
30 Days



Staar Surgical Co
Profile

Staar Surgical Co employs a business model focused on developing, manufacturing, and distributing implantable lenses used for the treatment of refractive errors such as myopia and astigmatism. The company primarily sells its products to eye surgeons and ophthalmologists globally, generating revenue through product sales and royalties from licensing agreements. By constantly innovating and expanding its product portfolio, Staar Surgical Co aims to improve vision outcomes for patients and maintain a competitive position in the ophthalmic market.

More about Staar Surgical Co's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,244.264 mill. $ 339.590 mill. $ 3.839 mill.


Rxsight Inc
Share Performance



-34.05%
One Year



Rxsight Inc
Profile

Rxsight Inc's business model revolves around providing innovative solutions in personalized vision correction through the use of adjustable intraocular lenses (IOLs).

More about Rxsight Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 266.424 mill. $ 127.178 mill. $ -46.638 mill.


Non Invasive Monitoring Systems Inc
Share Performance



+366,566.67%
One Year



Non Invasive Monitoring Systems Inc
Profile

Non Invasive Monitoring Systems Inc operates by providing non-invasive medical monitoring solutions that utilize advanced technologies to measure various physiological parameters for improved patient care in healthcare settings. Their business model focuses on developing and selling innovative monitoring devices and systems to healthcare professionals and institutions.

More about Non Invasive Monitoring Systems Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 11.359 mill. $ - mill. $ -0.550 mill.


Masimo Corp
Share Performance



+0.01%
Over The Past 5 Days



Masimo Corp
Profile

Masimo Corp is a medical technology company that focuses on developing and manufacturing innovative monitoring devices for patient care. Their business model revolves around creating and selling advanced noninvasive monitoring solutions to healthcare providers worldwide. They also generate revenue through licensing agreements, providing maintenance and support services, and selling disposable products and accessories related to their monitoring devices.

More about Masimo Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 9,465.370 mill. $ 1,557.000 mill. $ 76.300 mill.

5 more competitors available

Sign in to see all competitors

Sources: Warby Parker Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Warby Parker Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.